![]() |
|
![]() CBCTR 1st Generation Breast Cancer Progression Tissue Microarray (TMA)NOTE: The following information describes the tissue microarrays that were distributed by the CBCTR from 2002 to 2006. No new requests will be filled from these TMAs. A limited number of sections may still be available to investigators who previously received sections from these blocks and can provide a compelling justification. The CBCTR has designed a breast cancer Tissue microarray (TMA) that can be used to investigate differences in prevalence of potential markers in three stages of invasive breast cancer: node-negative, node-positive and metastatic disease. All of the invasive cases are primary breast cancers with a principal histology of ductal cancer accessioned through the CBCTR. The arrays were designed by National Cancer Institute statisticians to provide high statistical power for studies of stage specific markers of breast cancer. Each TMA block consists of 288 0.6 mm cores taken from paraffin-embedded specimens that represent 252 breast cancer and normal breast specimens plus 36 controls. Each array is created in quadruplicate to address possible tissue heterogeneity: four cores are taken from each specimen block, with one core per specimen appearing in each of the four replicate array blocks. The information provided for each case on the array will be: tumor size, TNM stage, number of nodes positive, grade, age at diagnosis and race. For additional details about the design of the CBCTR 1st Generation Progression TMA, see Case Sets 1-2 Design. The 252 normal breast and breast cancer cores appearing on each TMA block include:
The 36 control cores appearing on each TMA block include:
For information about tissue microarrays, please consult the National Human Genome Research Institute Tissue Microarray Project. To apply for tissue microarrays from the Resource, you must complete a Letter of Intent. |
![]() |
This page was last updated on:
Monday, April 10, 2006 at 10:01:58 AM. This page has been accessed Accessibility Feedback Form Comments to: tissueresources@imsweb.com |
|